Physician profile
Gary A Wasiak
NPI 1275696908
$708.96
in general payments reported to CMS, 2019-2025
14 companies · $17.90 in 2025
The $17.90 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $278 · 2021: $114 · 2022: $57.38 · 2023: $123 · 2024: $119 · 2025: $17.90.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $259.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $263.49 | 2021-2023 | Hoffmann |
| Amniox Medical, INC. | $100.00 | 2019 | |
| Paragon 28, INC. | $58.24 | 2019 | |
| Averitas Pharma INC. | $46.76 | 2024 | Qutenza |
| Musculoskeletal Transplant Foundation INC. | $41.30 | 2019 | |
| Axogen | $39.94 | 2019 | |
| Treace Medical Concepts, INC. | $37.78 | 2023-2024 | |
| Paratek Pharmaceuticals, INC. | $33.00 | 2024-2025 | Nuzyra |
| Mimedx Group, INC. | $21.55 | 2024 | |
| Organogenesis INC. | $14.35 | 2022 | |
| Bioventus LLC | $14.25 | 2019 | |
| Solventum Corporation | $13.88 | 2024 | Activ.A.C. |
| Horizon Therapeutics Plc | $13.32 | 2019 | |
| Merck Sharp & Dohme LLC | $11.10 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Wasiak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.